Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc. (CYTHW) Stock Overview

Explore Cyclo Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

CYTHW●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.03
$0.00(0.00%)
U.S. Market is Open · 13:55

Cyclo Therapeutics, Inc. (CYTHW)

Meyka AI Score

Z

Key Financials

Market Cap928K
P/E Ratio-0.59
EPS (TTM)N/A
ROE-7.30%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

CYTHW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cyclo Therapeutics, Inc. (NASDAQ: CYTHW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Cyclo Therapeutics, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CYTHW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Cyclo Therapeutics, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.59 and a market capitalization of 928K. Combined with our AI analysis, these give both institutional and retail investors a clear view of CYTHW on the NASDAQ.

Price Performance (NASDAQ: CYTHW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-45.85%
3-Month Change
-89.33%
6-Month Change
-77.14%
Year-to-Date (YTD) Change
-64.84%
1-Year Change
-85.46%
3-Year Change
-96.80%
5-Year Change
-97.87%
All-Time (Max) Change
-97.87%

Contact Information

http://www.cyclotherapeutics.com
NaN
6714 NW 16th Street, Gainesville, FL, 32653

Company Facts

80 Employees
IPO DateDec 18, 2020
CountryUS

Frequently Asked Questions